Horiguchi J - Search Results

1

Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.

Kurozumi S, Seki N, Narusawa E, Honda C, Tokuda S, Nakazawa Y, Yokobori T, Katayama A, Mongan NP, Rakha EA, Oyama T, Fujii T, Shirabe K, Horiguchi J. Kurozumi S, et al. Among authors: horiguchi j. Int J Mol Sci. 2023 Dec 19;25(1):35. doi: 10.3390/ijms25010035. Int J Mol Sci. 2023. PMID: 38203206 Free PMC article.

2

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.

3

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG. Pan H, et al. N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830. N Engl J Med. 2017. PMID: 29117498 Free PMC article.

4

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.

Swain SM, Miles D, Kim SB, Im YH, Im SA, Semiglazov V, Ciruelos E, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J; CLEOPATRA study group. Swain SM, et al. Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12. Lancet Oncol. 2020. PMID: 32171426 Clinical Trial.

5

Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer after Complete Resection.

Kanzaki R, Fukuda H, Kobayashi M, Horiguchi J, Kawagishi S, Maniwa T, Fujii M, Okami J. Kanzaki R, et al. Among authors: horiguchi j. Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15279-9. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38647914

6

Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers.

Katayama A, Aoki Y, Watanabe Y, Horiguchi J, Rakha EA, Oyama T. Katayama A, et al. Among authors: horiguchi j. Int J Clin Oncol. 2024 Apr 15. doi: 10.1007/s10147-024-02513-3. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38619651 Review.

7

Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer.

Narusawa E, Kurozumi S, Katayama A, Koibuchi Y, Ogawa A, Takata D, Tokuda S, Obayashi S, Oyama T, Horiguchi J, Shirabe K, Fujii T. Narusawa E, et al. Among authors: horiguchi j. Med Mol Morphol. 2024 Apr 15. doi: 10.1007/s00795-024-00386-z. Online ahead of print. Med Mol Morphol. 2024. PMID: 38619618

8

Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8⁺ T-cell infiltration in breast cancer.

Honda CK, Kurozumi S, Fujii T, Pourquier D, Khellaf L, Boissiere F, Horiguchi J, Oyama T, Shirabe K, Colinge J, Yokobori T, Turtoi A. Honda CK, et al. Among authors: horiguchi j. Theranostics. 2024 Feb 24;14(5):1873-1885. doi: 10.7150/thno.90627. eCollection 2024. Theranostics. 2024. PMID: 38505604 Free PMC article.

9

Fibrocystic breast disease with pleomorphic calcifications and segmental distribution: A case report.

JiueLan K, Sekine C, Kurozumi S, Matsuoka R, Komuta M, Shiomi T, Horiguchi J. JiueLan K, et al. Among authors: horiguchi j. Radiol Case Rep. 2023 Aug 25;18(11):3828-3830. doi: 10.1016/j.radcr.2023.08.010. eCollection 2023 Nov. Radiol Case Rep. 2023. PMID: 37670913 Free PMC article.

10

[Giant Mature Cystic Teratoma Causing Loss of Consciousness before Surgery].

Otake S, Oyama T, Murakami H, Horiguchi J, Fukutomi T, Kato R. Otake S, et al. Among authors: horiguchi j. Kyobu Geka. 2023 Apr;76(4):320-323. Kyobu Geka. 2023. PMID: 36997181 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

421 results

Search Page